Abstract
Human T-cell leukemia virus type 1 (HTLV-1) infects target cells primarily through cell-to-cell routes. Here, we provide evidence that cellular protein M-Sec plays a critical role in this process. When purified and briefly cultured, CD4+ T cells of HTLV-1 carriers, but not of HTLV-1- individuals, expressed M-Sec. The viral protein Tax was revealed to mediate M-Sec induction. Knockdown or pharmacological inhibition of M-Sec reduced viral infection in multiple co-culture conditions. Furthermore, M-Sec knockdown reduced the number of proviral copies in the tissues of a mouse model of HTLV-1 infection. Phenotypically, M-Sec knockdown or inhibition reduced not only plasma membrane protrusions and migratory activity of cells, but also large clusters of Gag, a viral structural protein required for the formation of viral particles. Taken together, these results suggest that M-Sec induced by Tax mediates an efficient cell-to-cell viral infection, which is likely due to enhanced membrane protrusions, cell migration, and the clustering of Gag.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Membrane / metabolism
-
Cell Membrane / virology*
-
Cell Movement
-
Coculture Techniques
-
Disease Models, Animal*
-
Gene Products, tax / genetics
-
Gene Products, tax / metabolism*
-
HTLV-I Infections / metabolism
-
HTLV-I Infections / transmission*
-
HTLV-I Infections / virology
-
Human T-lymphotropic virus 1 / physiology*
-
Humans
-
Mice
-
Mice, Inbred NOD
-
Mice, SCID
-
Tumor Necrosis Factors / genetics
-
Tumor Necrosis Factors / metabolism*
-
Viral Structural Proteins / genetics
-
Viral Structural Proteins / metabolism*
Substances
-
Gene Products, tax
-
M-sec protein, mouse
-
Tumor Necrosis Factors
-
Viral Structural Proteins
Grants and funding
This study was supported by grants (KAKENHI) from the Japan Society for the Promotion of Science (JSPS) (18K19457 to SS and MH, and 18K07155 to MH), a grant from the Japan Agency for Medical Research and Development (AMED) (19fk0410018h0002 to ON and MH), a grant from the SENSHIN Medical Research Foundation (to SS), and a grant from the Astellas Foundation for Research on Metabolic Disorders (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.